Patents/Assignees

SHANGHAI VITALGEN BIOPHARMA CO., Ltd.

5 patents in portfolio

US12605467utility2026
Recombinant AAV Vectors for Treating Neurodegenerative Disorders
0 cites
US12509490utility2025
AAV Capsids for Targeting Nervous System and Uses Thereof
0 cites
US12496562utility2025
Sinuous Microstructure Mixing Unit and Use Thereof
0 cites
US12491266utility2025
Recombinant AAV Vectors for Treating Glutaric Aciduria Type I
0 cites
US12371474utility2025
Recombinant Adeno-associated Viral Vectors for Treating Bietti Crystalline Dystrophy
0 cites